Vanguard Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242M | Buy |
4,529,628
+298,984
| +7% | +$16M | ﹤0.01% | 1424 |
|
|
2025
Q1 | $171M | Buy |
4,230,644
+526,233
| +14% | +$21.3M | ﹤0.01% | 1550 |
|
|
2024
Q4 | $103M | Buy |
3,704,411
+27,830
| +0.8% | +$774K | ﹤0.01% | 1859 |
|
|
2024
Q3 | $105M | Sell |
3,676,581
-28,509
| -0.8% | -$818K | ﹤0.01% | 1848 |
|
|
2024
Q2 | $86.9M | Buy |
3,705,090
+35,167
| +1% | +$825K | ﹤0.01% | 1900 |
|
|
2024
Q1 | $92.7M | Buy |
3,669,923
+584,875
| +19% | +$14.8M | ﹤0.01% | 1903 |
|
|
2023
Q4 | $72M | Buy |
3,085,048
+72,866
| +2% | +$1.7M | ﹤0.01% | 2026 |
|
|
2023
Q3 | $152M | Buy |
3,012,182
+326,308
| +12% | +$16.5M | ﹤0.01% | 1573 |
|
|
2023
Q2 | $125M | Buy |
2,685,874
+546,981
| +26% | +$25.5M | ﹤0.01% | 1730 |
|
|
2023
Q1 | $81.8M | Buy |
2,138,893
+22,322
| +1% | +$854K | ﹤0.01% | 1917 |
|
|
2022
Q4 | $116M | Buy |
2,116,571
+375,978
| +22% | +$20.6M | ﹤0.01% | 1727 |
|
|
2022
Q3 | $59.3M | Buy |
1,740,593
+429,579
| +33% | +$14.6M | ﹤0.01% | 2100 |
|
|
2022
Q2 | $12.4M | Buy |
1,311,014
+84,103
| +7% | +$795K | ﹤0.01% | 2872 |
|
|
2022
Q1 | $17.4M | Buy |
1,226,911
+56,492
| +5% | +$802K | ﹤0.01% | 2848 |
|
|
2021
Q4 | $24.8M | Buy |
1,170,419
+89,834
| +8% | +$1.9M | ﹤0.01% | 2726 |
|
|
2021
Q3 | $24.2M | Buy |
1,080,585
+20,949
| +2% | +$468K | ﹤0.01% | 2750 |
|
|
2021
Q2 | $26.3M | Buy |
1,059,636
+73,916
| +7% | +$1.83M | ﹤0.01% | 2705 |
|
|
2021
Q1 | $28.6M | Buy |
985,720
+102,157
| +12% | +$2.96M | ﹤0.01% | 2605 |
|
|
2020
Q4 | $22.8M | Buy |
883,563
+29,790
| +3% | +$769K | ﹤0.01% | 2571 |
|
|
2020
Q3 | $26.3M | Buy |
853,773
+313,697
| +58% | +$9.66M | ﹤0.01% | 2323 |
|
|
2020
Q2 | $13.5M | Buy |
540,076
+233,357
| +76% | +$5.82M | ﹤0.01% | 2622 |
|
|
2020
Q1 | $6.5M | Buy |
306,719
+22,123
| +8% | +$469K | ﹤0.01% | 2831 |
|
|
2019
Q4 | $6.32M | Buy |
284,596
+100,071
| +54% | +$2.22M | ﹤0.01% | 3086 |
|
|
2019
Q3 | $4.2M | Buy |
184,525
+154,525
| +515% | +$3.52M | ﹤0.01% | 3200 |
|
|
2019
Q2 | $574K | Buy |
+30,000
| New | +$574K | ﹤0.01% | 3802 |
|